| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Issuance( Retirement)of Debt Net | 738.56 | -231.23 | -17.23 | 109.81 |
| Net Changein Cash | -36.73 | 44.73 | 14.40 | -36.97 |
| Cash Taxes Paid | 71.40 | 19.85 | 60.70 | 123.43 |
| Net Income/ Starting Line | 707.18 | 631.83 | 354.59 | 620.11 |
| Total Cash Dividends Paid | -216.22 | -157.25 | -196.56 | -275.19 |
| Changesin Working Capital | -992.74 | -115.49 | -118.26 | -490.79 |
| Cashfrom Operating Activities | 87.97 | 803.21 | 723.96 | 552.35 |
| Cash Interest Paid | 78.59 | 49.37 | 49.70 | 51.92 |
| Cashfrom Financing Activities | 443.71 | -437.87 | -261.96 | -217.35 |
| Depreciation/ Depletion | 278.58 | 272.67 | 275.43 | 286.78 |
| Other Investing Cash Flow Items Total | -4.79 | 6.86 | -4.18 | 53.67 |
| Capital Expenditures | -563.62 | -327.47 | -443.41 | -425.64 |
| period Type | - | - | - | - |
| Non- Cash Items | 94.95 | 14.20 | 212.20 | 136.25 |
| Financing Cash Flow Items | -78.63 | -49.39 | -48.17 | -51.97 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Cashfrom Investing Activities | -568.41 | -320.61 | -447.59 | -371.97 |
| Foreign Exchange Effects | - | - | -0.01 | 0.00 |
| Issuance( Retirement)of Stock Net | - | - | - | 0.00 |
Alembic Pharmaceuticals Dividend Alembic Pharmaceuticals Bonus Alembic Pharmaceuticals News Alembic Pharmaceuticals AGM Alembic Pharmaceuticals Rights Alembic Pharmaceuticals Splits Alembic Pharmaceuticals Board Meetings Alembic Pharmaceuticals Key Metrics Alembic Pharmaceuticals Shareholdings Alembic Pharmaceuticals Profit Loss Alembic Pharmaceuticals Balance Sheet Alembic Pharmaceuticals Q1 Results Alembic Pharmaceuticals Q2 Results Alembic Pharmaceuticals Q3 Results Alembic Pharmaceuticals Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks